Role of hypoxia in cancer therapy by regulating the tumor microenvironment
X Jing, F Yang, C Shao, K Wei, M Xie, H Shen, Y Shu - Molecular cancer, 2019 - Springer
Aim Clinical resistance is a complex phenomenon in major human cancers involving
multifactorial mechanisms, and hypoxia is one of the key components that affect the cellular …
multifactorial mechanisms, and hypoxia is one of the key components that affect the cellular …
Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations
KE Pendleton, K Wang, GV Echeverria - Frontiers in Cell and …, 2023 - frontiersin.org
Deregulation of tumor cell metabolism is widely recognized as a “hallmark of cancer.” Many
of the selective pressures encountered by tumor cells, such as exposure to anticancer …
of the selective pressures encountered by tumor cells, such as exposure to anticancer …
NEK2 promotes aerobic glycolysis in multiple myeloma through regulating splicing of pyruvate kinase
Z Gu, J Xia, H Xu, I Frech, G Tricot, F Zhan - Journal of hematology & …, 2017 - Springer
Background Aerobic glycolysis, a hallmark of cancer, is characterized by increased
metabolism of glucose and production of lactate in normaxia. Recently, pyruvate kinase M2 …
metabolism of glucose and production of lactate in normaxia. Recently, pyruvate kinase M2 …
Myeloma and bone disease
Abstract Purpose of Review Bone disease is a defining characteristic of multiple myeloma
(MM) and the major cause of morbidity. It manifests as lytic lesions or osteopenia and is …
(MM) and the major cause of morbidity. It manifests as lytic lesions or osteopenia and is …
Hypoxia-mediated decrease of ovarian cancer cells reaction to treatment: significance for chemo-and immunotherapies
A Klemba, L Bodnar, H Was, KK Brodaczewska… - International journal of …, 2020 - mdpi.com
Hypoxia, a common factor ruling the microenvironment composition, leads to tumor
progression. In this hypoxic context, cytokines and cells cooperate to favor cancer …
progression. In this hypoxic context, cytokines and cells cooperate to favor cancer …
CDK7 controls E2F-and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma
Y Yao, JF Ng, WD Park, M Samur… - Blood, The Journal …, 2023 - ashpublications.org
Therapeutic targeting of CDK7 has proven beneficial in preclinical studies, yet the off-target
effects of currently available CDK7 inhibitors make it difficult to pinpoint the exact …
effects of currently available CDK7 inhibitors make it difficult to pinpoint the exact …
LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma
X Yang, H Ye, M He, X Zhou, N Sun, W Guo… - Biochemical and …, 2018 - Elsevier
Multiple myeloma (MM), the second most common hematologic malignancy, is an incurable
disease characterized by the accumulation of malignant plasma cells within the bone …
disease characterized by the accumulation of malignant plasma cells within the bone …
[HTML][HTML] The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance
B Polónia, CPR Xavier, J Kopecka, C Riganti… - Cytokine & Growth …, 2023 - Elsevier
In order to adapt to a higher proliferative rate and an increased demand for energy sources,
cancer cells rewire their metabolic pathways, a process currently recognized as a hallmark …
cancer cells rewire their metabolic pathways, a process currently recognized as a hallmark …
Metabolic features of multiple myeloma
C El Arfani, K De Veirman, K Maes… - International journal of …, 2018 - mdpi.com
Cancer is known for its cellular changes contributing to tumour growth and cell proliferation.
As part of these changes, metabolic rearrangements are identified in several cancers …
As part of these changes, metabolic rearrangements are identified in several cancers …
Signaling interplay between bone marrow adipose tissue and multiple myeloma cells
In the year 2000, Hanahan and Weinberg defined the six Hallmarks of Cancer as: self-
sufficiency in growth signals, evasion of apoptosis, insensitivity to antigrowth mechanisms …
sufficiency in growth signals, evasion of apoptosis, insensitivity to antigrowth mechanisms …